Recent Advancements, Challenges, and Future Prospects in Usage of Nanoformulation as Theranostics in Inflammatory Diseases

As of today, chronic inflammatory diseases are a progressive cause death worldwide, accounting for more than 50% all fatalities. These conditions major concern, ranging from heart disease to cancer, diabetes, even neurodegenerative conditions. Conventional diagnosis and treatment these problems often challenging limited due complex pathophysiology. To improve upon current diagnostic strategies, theranostic nanomaterials have been developed. Theranostics is an amalgamation biomarkers therapeutic medicines that shared target in damaged cells or tissues. Different nanoparticles generate enhanced imaging results facilities such as MRI, PET scan, CT scans depending on the site inflammation different organs. Furthermore, they can be treated with radiopharmaceuticals and/or medicine nanoparticles. Following brief discussion conventional this review will cover recent progress made nanomedicine tactics managing disorders, covering preclinical clinical stages advances past five years. present challenges detection discussed, well future research possibilities.